Synthesis of silver nanoparticles from abelmoschus esculentus extract
10059601 ยท 2018-08-28
Assignee
Inventors
Cpc classification
A61K9/5176
HUMAN NECESSITIES
A61K9/148
HUMAN NECESSITIES
B22F2999/00
PERFORMING OPERATIONS; TRANSPORTING
Y02A50/30
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
B22F9/24
PERFORMING OPERATIONS; TRANSPORTING
A61K2236/331
HUMAN NECESSITIES
A61K2236/15
HUMAN NECESSITIES
B22F1/0545
PERFORMING OPERATIONS; TRANSPORTING
B22F2999/00
PERFORMING OPERATIONS; TRANSPORTING
B22F1/0545
PERFORMING OPERATIONS; TRANSPORTING
A61K2236/53
HUMAN NECESSITIES
C01P2004/64
CHEMISTRY; METALLURGY
International classification
B22F9/24
PERFORMING OPERATIONS; TRANSPORTING
A61K9/14
HUMAN NECESSITIES
Abstract
The synthesis of silver nanoparticles from plant extract includes providing a solution including silver nitrate; providing an aqueous extract of the Abelmoschus esculentus (Okra) plant or plant part; mixing the silver nitrate solution and the extract solution to form an aqueous mixture; and resting the aqueous mixture for a period of time to form silver nanoparticles (AgNPs). The resulting silver nanoparticles demonstrate antimicrobial activity against both gram-positive and gram-negative pathogens.
Claims
1. A method of synthesizing silver nanoparticles, comprising the steps of: providing a silver nitrate solution; providing an aqueous extract of Abelmoschus esculentus, wherein the aqueous extract of Abelmoschus esculentus is derived from dried flowers of Abelmoschus esculentus; mixing the silver nitrate solution with the aqueous extract of Abelmoschus esculentus to provide a mixture; and resting the mixture at room temperature for an amount of time to produce a suspension including the silver nanoparticles.
2. The method of synthesizing silver nanoparticles of claim 1, wherein said silver nitrate solution is prepared by dissolving about 1 mM silver nitrate in about 250 double distilled water.
3. The method of synthesizing silver nanoparticles of claim 1, wherein providing the aqueous extract comprises grinding said dried flowers of Abelmoschus esculentus into a fine powder and soaking the fine powder in water.
4. The method of synthesizing silver nanoparticles of claim 3, wherein about 5 grams of the fine powder is soaked in about 100 ml of double distilled water for about 24 hours to produce the extract solution.
5. The method of synthesizing silver nanoparticles of claim 4, further comprising the step of filtering the extract solution.
6. The method of synthesizing silver nanoparticles of claim 1, wherein the amount of time for the resting step is about 24 to about 72 hours.
7. The method of synthesizing silver nanoparticles of claim 6, wherein the amount of time for the resting step is about 72 hours.
8. A method of synthesizing silver nanoparticles, comprising the steps of: providing a silver nitrate solution; providing an aqueous extract of Abelmoschus esculentus, wherein the aqueous extract of Abelmoschus esculentus is derived from dried flowers of Abelmoschus esculentus; mixing the silver nitrate solution with the aqueous extract of Abelmoschus esculentus to provide a mixture; and resting the mixture at room temperature for an amount of time to produce a suspension including the silver nanoparticles, wherein the silver nanoparticles have an average diameter of about 13.24 nanometers.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16) Similar reference characters denote corresponding features consistently throughout the attached drawings.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
(17) The synthesis of silver nanoparticles (AgNPs) from a plant extract includes providing a solution including silver nitrate; providing an aqueous extract of the Abelmoschus esculentus (Okra) plant or plant part; mixing the silver nitrate solution and the extract solution to form an aqueous mixture; and resting the aqueous mixture for a period of time to form a suspension including silver nanoparticles (AgNPs). Synthesis of the silver nanoparticles (AgNPs) can begin about 24, about 48, or about 72 hours after mixing. The resulting AgNPs can have a particle size ranging from about 5 nm to about 19 nm.
(18) The suspension including the AgNPs may be used as antimicrobial agents. For example, the suspension including AgNPs can effectively inhibit or prevent growth of gram positive and gram negative bacteria. An effective amount of the suspension can be contacted with the pathogen or locus of the pathogen to prevent or inhibit growth thereof.
(19) The extract can be a flower extract derived from Okra flowers. As used herein, the term flower extract includes, for example, any chemical or combination of chemicals found in the flower of the plant, as well as any derivatives of the chemicals or compounds found in the flower via extraction. The flower extract can be obtained from the plant by any process, including but not limited to cold water extraction, hot water extraction, or extraction using an organic solvent. The resulting AgNPs may be used as antimicrobial agents against gram positive and gram negative pathogens. The following examples will further illustrate the synthesis process.
Example 1
Synthesis of Silver Nanoparticles from Okra Flowers
(20) AgNPs were synthesized by the following method. Fresh Okra flowers were collected from an organic agriculture farm house in the Riyadh region of the Kingdom of Saudi Arabia. About 250 grams of flower were taken and the flowers were dried at room temperature, producing dried Okra flowers. The dried Okra flowers were ground into a fine powder and then about 5 grams of powder was soaked in about 100 ml of double distilled water (DH.sub.2O) for about 24 hours, producing aqueous Okra flower extract. The aqueous Okra flower extract was filtered using Whatman No. 1 filter paper, producing filtered, aqueous Okra flower extract. The filtered flower extract was dark black in color. About 1 mM silver nitrate (AgNO.sub.3) was dissolved by mixing in about 250 ml of DH.sub.2O, producing a silver nitrate solution. About 5 ml of the filtered Okra flower extract was added to the silver nitrate solution and mixed thoroughly, forming an aqueous mixed solution. The aqueous mixed solution was then rested at room temperature for up to about 72 hours. After about 72 hours, the aqueous mixed solution was observed to change from colorless to dark brown. This color change is visual evidence of formation of AgNps or reduction of silver ions into AgNPs.
(21) The synthesis of Okra flower AgNPs was first confirmed by ultraviolet-visible spectroscopy.
(22) The synthesis of AgNPs was next confirmed by X-ray diffraction.
(23) The AgNPs were also analyzed using FTIR. The FTIR spectrum obtained from Okra flower AgNPs is shown in
(24)
(25)
Example 2
Establishing Antimicrobial Activity of Okra Flower AgNPs
(26) Antimicrobial activity of Okra flower AgNPs was tested using the agar diffusion method. Standardized inoculums of about 1-2107 colony forming units per milliliter with about 0.5 Mcfarl were prepared and introduced onto the surface of sterile agar plates. Sterile glass spreaders were used for even distribution of the inoculums. Five evenly spaced wells were created around the outer area of each plate, along with a central control well. Different concentrations (of about 5 L, about 10 L, about 25 L, about 50 L, and about 100 L) of the Okra flower AgNPs were poured into individual wells. The antibiotic control used was 5 g per mL Ciprofloxacin. The inhibition zones were measured in millimeters after about 24 hours of incubation at about 37 degrees Celsius. The antimicrobial activity of Okra flower AgNPs was assessed using gram negative pathogens Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27584), Proteus vulgaris (ATCC 8427), Salmonella typhimurium (ATCC 14028) and Shigella sonnei (King Khalid Medical Hospital Riyadh), as shown in
(27) TABLE-US-00001 TABLE 1 Antimicrobial Activity of Okra Flower AgNPs Inhibition Zone Diameter (mm) Organism 5 L 10 L 25 L 50 L 100 L Escherichia coli 6 14 Pseudomonas aeruginosa 10 16 Proteus vulgaris Salmonellatyphimurium 6 10 18 Shigella sonnei 6 12 Bacillus subtilis 6 7 8 12 Klebsiella pneumoniae 8 16 Staphylococcus aureus 6 7 9 10 12 Staphylococcus pidermidis 6 7 10 13 Streptococcus pyogenes 6 7 12
(28) It is to be understood that the present invention is not limited to the embodiments described above, but encompasses any and all embodiments within the scope of the following claims.